Bone marrow transplants, already used to treat some children with sickle cell disease, also may cure some adults with this deadly genetic defect that causes red blood cells to contort, U.S. scientists said on Wednesday.
A relatively low birth weight and early-age weight gain may increase the likelihood of early puberty, hint findings from a German study. Earlier onset of puberty has been linked to certain cancers, high blood sugar and obesity.
About 3 million Americans suffer from the most common type of abnormal heart rhythm, atrial fibrillation, and that number is likely to double by 2035, new research shows.
Women who took a commonly used class of osteoporosis drugs called bisphosphonates had significantly fewer invasive breast cancers than women not using the bone-strengthening pills, according to a new analysis of data from the Women's Health Initiative (WHI).
What if a single drug could cure obesity? According to some research I've been following, we're not far off from that reality. There's no question that whoever controls the market for such a groundbreaking obesity drug holds the keys to mind-blowing wealth. Here's everything you need to know for a shot at the ground floor...
Liz Sequeira, a 52-year-old primary care physician, is too young to remember when U.S. doctors made routine house calls. So to her, seeing patients in her three exam rooms on the first floor of Discovery Communications Inc's (DISCA.O) modern headquarters is like stepping back in time.
President Barack Obama said Wednesday he will allocate nearly $600 million from the $787 billion economic stimulus plan to help create jobs at 85 community health centers.
Shares of U.S. health insurers rose on Wednesday after efforts to overhaul the health system moved away from creating a government-run insurance plan long viewed as damaging to the industry.
GlaxoSmithKline has started a second large-scale clinical trial with experimental heart drug darapladib, increasing its investment in the new type of medicine for clogged arteries.
Is soy food helpful or harmful for women with breast cancer? Studies have yielded mixed results. A new study published today suggests that breast cancer survivors may benefit from eating moderate amounts of soy products.
Health experts warned Wednesday of a stroke crisis in Europe which is already costing the region's economy an estimated 38 billion euros ($56 billion) a year, with numbers expected to rise as populations age.
Children and young people who survive cancer have a significantly higher risk of developing heart disease as young adults because of the cancer treatment they received, researchers said Wednesday.
U.S. advisers felt MRI imaging drugs from GE Healthcare and Covidien appear to carry a higher risk of a serious skin disease in some patients than similar products, a Food and Drug Administration official said on Tuesday.
Residents of poor neighborhoods may die sooner than residents of wealthier neighborhoods - regardless of what they eat, how active they are, or other individual risk factors, new research suggests.
Roche Holding AG said on Wednesday three studies on its drugs used to treat early and advanced breast cancer showed good results.
As little as 15 minutes of physical activity a day can substantially cut death rates in men with prostate cancer, new research hints.
Holding off on introducing certain foods in order to prevent children from becoming allergic to them may be counterproductive.
About 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said Tuesday.
There is no clear evidence that Roche's widely used drug Tamiflu prevents complications such as pneumonia in people with flu, a group of medical experts said on Tuesday.
Michelle Duggar who stars on TLC's 18 Kids and Counting updated her fans about her health through a video posted on People Magazine.
U.S. Food and Drug Administration staff cited concerns on Tuesday with the design and analysis of clinical studies intended to support the effectiveness of Gilead Sciences Inc's experimental cystic fibrosis drug.
Celgene Corp investors
were struggling on Tuesday to sort through confusing results
from a key trial of the company's cancer drug Revlimid.
